Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
HotStart 2X Green qPCR Master Mix Workflow
2026-09-09
Build more defensible SYBR Green assays for gene expression, RNA-seq validation, and nucleic acid quantification with a hot-start workflow designed to limit nonspecific amplification. The approach also shows how qPCR can support mRNA nanovaccine studies without confusing assay validation with therapeutic efficacy.
-
(R,S)-Anatabine: Aβ Assay Strategy
2026-09-08
Explore how (R,S)-Anatabine connects APP processing, BACE-1 regulation, and NF-κB signaling in Alzheimer’s disease research. This guide adds a cross-disciplinary assay-design perspective based on mechanistic lessons from epidermal homeostasis research.
-
Acifran: HCAR2/HCAR3 Signaling Guide
2026-09-08
Acifran, also known as (R)-5-methyl-4-oxo-5-phenyl-4,5-dihydrofuran-2-carboxylic acid, is a research agonist used to study HCAR2/GPR109A and HCAR3/GPR109B signaling. Cryo-EM evidence places Acifran in both HCAR3-Gi and HCAR2-Gi complexes, supporting its use in receptor recognition and lipid metabolism research.
-
MALAT1–miR-125b/STAT3 Control of PCT in Sepsis
2026-09-07
The reference study identifies a MALAT1–miR-125b–STAT3 regulatory axis that increases procalcitonin expression in sepsis-related inflammatory models. Its combination of patient samples, LPS-stimulated U937 cells, localization analysis, target validation, and rescue experiments provides a mechanistic framework for interpreting PCT regulation while also highlighting limits in translating cell-model findings to clinical practice.
-
Concanamycin A: Reliable V-ATPase Assays
2026-09-07
This scenario-driven guide explains how Concanamycin A (SKU A8633) can clarify viability, apoptosis, trafficking, and invasion results in cancer biology research. It connects mechanism, protocol design, data interpretation, and practical product-selection criteria for more defensible cell-based assays.
-
Lactate Workflows for Metabolic–Immune Research
2026-09-05
Use L-lactate as both a quantitative metabolic readout and a controlled signaling input in glycolysis, hypoxia, mitochondrial, and tumor–immune experiments. This workflow emphasizes compartment-aware sampling, matched controls, and mechanistic validation around the NAT1–ENO1–lactate–PD-L1 axis.
-
LG 101506: A Mechanism-First RXR Guide
2026-09-04
Explore LG 101506 as an RXR modulator through a mechanism-first framework linking nuclear receptor assays with checkpoint biology. Learn how the RBMS1–B4GALT1–PD-L1 study can inform controls, endpoints, and interpretation without overstating evidence.
-
GSK J4 HCl: JMJD3 Inhibition Workflows
2026-09-04
GSK J4 HCl enables cell-based testing of JMJD3-dependent H3K27 demethylation across inflammatory, decidual, and tumor models. This practical guide connects chromatin occupancy with cytokine output, highlights controls, and provides troubleshooting strategies for more causal epigenetic regulation research.
-
DSS (MW 35000-45000) for Colitis Repair
2026-09-03
Dextran sulfate sodium salt (MW 35000-45000) provides a practical epithelial-injury platform for modeling colitis, testing barrier-restoring therapies, and resolving the transition from mucosal damage to repair. This workflow connects DSS injury phenotypes with the GPR35–KLF5 repair circuit and emphasizes dosing control, time-resolved sampling, and troubleshooting.
-
Zosuquidar: P-gp Inhibition in Cancer Assays
2026-09-03
Zosuquidar (LY335979) 3HCl provides a practical way to test whether P-glycoprotein efflux is driving chemotherapy or PROTAC resistance. This guide translates its use into paired-cell assays, drug-sensitization workflows, resistance-mechanism studies, and troubleshooting decisions.
-
YM-155 Hydrochloride: Assay Workflow Guide
2026-09-02
YM-155 hydrochloride provides a selective survivin inhibitor framework for separating proliferation arrest from cell death in cancer assays. This guide translates the reference study into practical dose-response, orthogonal readout, xenograft-translation, and troubleshooting workflows.
-
Camostat Mesilate Workflows for Protease Research
2026-09-02
Camostat Mesilate supports mechanism-focused studies of ENaC function, plasmin–TGF-β signaling, and hepatic stellate cell activation. This practical guide combines assay setup, formulation controls, fibrosis workflows, and a careful comparison with structure-guided protein–protein interaction inhibitors.
-
Chromatin Programs in Perinatal Cardiomyocyte Transition
2026-09-01
The reference study maps coordinated changes in chromatin accessibility, long-range regulatory interactions, and gene expression during the perinatal transition of cardiomyocytes. Its identification of MEF2- and AP1-centered regulatory programs provides a framework for interpreting maturation and for improving the transcriptional state of induced pluripotent stem cell-derived cardiomyocytes.
-
Annexin V-FITC/PI Apoptosis Assay Kit Workflow
2026-09-01
Learn how to use the Annexin V-FITC/PI Apoptosis Assay Kit to separate viable, early apoptotic, late apoptotic, and membrane-compromised cells in drug-response studies. The workflow connects rapid two-color staining with flow cytometry, microscopy, hypoxia experiments, and phototherapeutic cancer research.
-
Haloprogin: Applied Antifungal Workflows
2026-08-31
Haloprogin supports practical assay design across dermatophyte, Candida, and selected Gram-positive bacterial models. This guide connects MIC/MFC testing with topical formulation and guinea pig infection workflows while emphasizing solvent control, matrix effects, and reproducibility.